Most not long ago, it's been recognized that conolidine and the above derivatives act over the atypical chemokine receptor three (ACKR3. Expressed in identical locations as classical opioid receptors, it binds to some big range of endogenous opioids. Unlike most opioid receptors, this receptor acts for a scavenger and isn't going to activate a next